Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
Journal of Hepatology|June 10, 2019
Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysisThomas Yau, Chiun Hsu, Tae-You Kim, et al.The Oncologist|November 20, 2024
Real-world effectiveness and prognostic factors of durvalumab plus chemotherapy in a multicentric cohort with advanced biliary tract cancerWen-Kuan Huang, Yan-Jei Tang, Chiao-En Wu, et al.The Oncologist|March 26, 2024
Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular CarcinomaChung-Wei Su, Wei Teng, Eric Yi-Liang Shen, et al.Anticancer Research|April 12, 2012
Comparison of genomic signatures of non-small cell lung cancer recurrence between two microarray platformsJohn Wen-Cheng Chang, Nien-Chih Wei, Hung-Ju Su, et al.Biomedical Journal|January 27, 2024
Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancerJohn Wen-Cheng Chang, Jia-Juan Hsieh, Chih-Yu Tsai, et al.Biomedical Journal|May 17, 2026
External validation of MAGIC-D model in Taiwanese patients with advanced biliary tract cancer receiving durvalumab and chemotherapyChung-Hao Ku, Wen-Kuan Huang, Chun-Feng Wu, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 27, 2023
Personalized neoantigen-based T cell therapy triggers cytotoxic lymphocytes expressing polyclonal TCR against metastatic ovarian cancerShuen-Iu Hung, Mu-Tzu Chu, Ming-Mo Hou, et al.Biomedical Journal|September 3, 2014
Early radiographic response to epidermal growth factor receptor-tyrosine kinase inhibitor in non-small cell lung cancer patients with epidermal growth factor receptor mutations: A prospective studyJohn W C Chang, Ming-Mo Hou, Jia-Juan Hsieh, et al.Biomedicines|November 26, 2022
Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy EraWing-Keen Yap, Ming-Chieh Shih, Yu-Chen Chang, et al.Journal of Cancer|December 1, 2025
Validation of WHO 2017 Classification and Identification of Prognostic Factors in Patients with Pancreatic Neuroendocrine Neoplasms: A Real-World Experience in TaiwanWei-Pang Ho, Wen-Chi Chou, Chia-Hsun Hsieh, et al.Pageof 7